Company Akoya Biosciences, Inc.

Equities

AKYA

US00974H1041

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 01:30:00 02/05/2024 am IST 5-day change 1st Jan Change
3.96 USD +3.66% Intraday chart for Akoya Biosciences, Inc. +3.94% -18.85%

Business Summary

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Number of employees: 330

Sales per Business

USD in Million2022Weight2023Weight Delta
Instruments
43.6 %
39 51.6 % 42 43.6 % +8.96%
Service and Other
30.2 %
17 23.0 % 29 30.2 % +69.81%
Consumables
25.0 %
18 24.6 % 24 25.0 % +31.31%
Standalone Software
1.2 %
1 0.8 % 1 1.2 % +85.69%

Sales per region

USD in Million2022Weight2023Weight Delta
North America
60.3 %
42 56.2 % 58 60.3 % +38.62%
EMEA
22.6 %
18 23.7 % 22 22.6 % +22.76%
APAC
17.1 %
15 20.1 % 17 17.1 % +9.93%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 01/17/01
Director of Finance/CFO 48 20/23/20
Chief Tech/Sci/R&D Officer - 26/21/26
Chief Operating Officer 65 31/21/31
Chief Tech/Sci/R&D Officer - 01/18/01
Investor Relations Contact - -
General Counsel 53 28/23/28
Corporate Officer/Principal - 01/20/01
- -
Corporate Officer/Principal 49 01/20/01

Members of the board

Members of the board TitleAgeSince
Chairman 67 01/15/01
Director/Board Member 66 16/21/16
Director/Board Member 67 01/19/01
Director/Board Member 71 01/17/01
Director/Board Member 77 01/15/01
Chief Executive Officer 55 01/17/01
Director/Board Member 57 11/21/11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 49,140,731 25,340,022 ( 51.57 %) 0 51.57 %

Shareholders

NameEquities%Valuation
Telegraph Hill Partners Management Co. LLC
35.97 %
17,675,247 35.97 % 83 M $
Blue Water Life Science Advisors LP
9.560 %
4,697,785 9.560 % 22 M $
PSC Capital Partners LLC
7.158 %
3,517,360 7.158 % 16 M $
aMoon Ventures Y Sh Ltd.
6.262 %
3,077,195 6.262 % 14 M $
1,579,756 3.215 % 7 M $
Vanguard Fiduciary Trust Co.
2.866 %
1,408,157 2.866 % 7 M $
BlackRock Advisors LLC
2.683 %
1,318,497 2.683 % 6 M $
984,513 2.003 % 5 M $
Parkman Healthcare Partners LLC
1.373 %
674,787 1.373 % 3 M $
Uniplan Investment Counsel, Inc.
1.371 %
673,523 1.371 % 3 M $

Company contact information

Akoya Biosciences, Inc.

100 Campus Drive 6th Floor

01752, Marlborough

+

http://www.akoyabio.com
address Akoya Biosciences, Inc.(AKYA)
  1. Stock Market
  2. Equities
  3. AKYA Stock
  4. Company Akoya Biosciences, Inc.